Product Information
BRIVIACT 75 MG TABLET is a brand product labeled by UCB, Inc., priced at $24.0487 per EA under NDC 50474067066. Its NADAC has been published 331 times since Apr 22, 2020.
FDA first approved this application on May 12, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
75 mg/1
Manufacturer
UCB, Inc.NDC
50474067066
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
BRIVARACETAMApproval Type
New Drug (NDA)
FDA Application
NDA205836FDA Approved
5/12/2016
TE Code
AB
On Market Since
5/12/2016
Pharmacological Classes
Price Statistics
The NADAC for BRIVIACT 75 MG TABLET has been published 331 times since Apr 22, 2020, and over the history we have for it it has risen 28.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $24.0487 per EA |
|---|---|
| All-time high | $24.0907 (May 13, 2026) |
| All-time low | $18.7746 (Apr 22, 2020) |
| 52-week high | $24.0907 |
| 52-week low | $23.4793 |
| Median price | $22.0745 |
| Average price | $21.6592 |
| Largest weekly change | +6.9% (Jan 12, 2022) |
| Weeks tracked | 331 |
| Tracking since | Apr 22, 2020 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the brivaracetam market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BRIVIACT 75 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BRIVIACT 75 MG TABLET, manufactured by UCB, Inc., is $24.0487 per EA (NDC 50474067066), effective Aug 19, 2026.
How has the price of BRIVIACT 75 MG TABLET changed over time?
Over the history we have for it, the NADAC for BRIVIACT 75 MG TABLET has risen 28.1%. It has been tracked across 331 weekly CMS publications since Apr 22, 2020.
What are the highest and lowest recorded NADAC prices for BRIVIACT 75 MG TABLET?
Since Apr 22, 2020, the NADAC for BRIVIACT 75 MG TABLET has ranged from a low of $18.7746 (Apr 22, 2020) to a high of $24.0907 (May 13, 2026), with a median of $22.0745 per EA.
Are there cheaper alternatives to BRIVIACT 75 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of BRIVIACT 75 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures BRIVIACT 75 MG TABLET?
BRIVIACT 75 MG TABLET (NDC 50474067066) is labeled by UCB, Inc., and CMS classifies it as a brand product.